Literature DB >> 8192812

Encephalopathy from abuse of bismuth subsalicylate (Pepto-Bismol)

A C Jungreis1, H H Schaumburg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8192812     DOI: 10.1212/wnl.43.6.1265

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  9 in total

1.  A 54-year-old man with slowness of movement and confusion.

Authors:  Michael D Geschwind; Keith A Josephs; Joseph E Parisi; B Mark Keegan
Journal:  Neurology       Date:  2007-11-06       Impact factor: 9.910

2.  Radio-opaque punctate opacities on the chest radiograph following intravenous injection of a bismuth compound.

Authors:  D J Addrizzo-Harris; A Churg; W N Rom
Journal:  Thorax       Date:  1997-03       Impact factor: 9.139

Review 3.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

Review 4.  Acute renal failure after overdose of colloidal bismuth subcitrate.

Authors:  Nurcan Cengiz; Yasemin Uslu; Faysal Gök; Ali Anarat
Journal:  Pediatr Nephrol       Date:  2005-06-10       Impact factor: 3.714

5.  Reversible dementias.

Authors:  Manjari Tripathi; Deepti Vibha
Journal:  Indian J Psychiatry       Date:  2009-01       Impact factor: 1.759

Review 6.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Huidy Shu; Aissa Haman; James J Sejvar; Bruce L Miller
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

Review 7.  Calcium-sensing receptor: A new target for therapy of diarrhea.

Authors:  Sam Xianjun Cheng
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

Review 8.  Drug-induced myoclonus: frequency, mechanisms and management.

Authors:  Félix Javier Jiménez-Jiménez; Inmaculada Puertas; María de Toledo-Heras
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 9.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Aissa Haman; Bruce L Miller
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.